| scholarly article | Q13442814 |
| P50 | author | Thomas Efferth | Q53683811 |
| P2093 | author name string | Gerold Schuler | |
| Andreas Baur | |||
| Erwin S Schultz | |||
| Thomas G Berger | |||
| Detlef Dieckmann | |||
| Jens-Oliver Funk | |||
| P433 | issue | 6 | |
| P921 | main subject | artesunate | Q707939 |
| P304 | page(s) | 1599-1603 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Oncology Reports | Q7092098 |
| P1476 | title | Artesunate in the treatment of metastatic uveal melanoma--first experiences | |
| P478 | volume | 14 |
| Q22061945 | A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer |
| Q38414908 | Anticancer Effect of AntiMalarial Artemisinin Compounds |
| Q28538116 | Anticancer properties of distinct antimalarial drug classes |
| Q24655984 | Antimelanoma activity of the redox dye DCPIP (2,6-dichlorophenolindophenol) is antagonized by NQO1 |
| Q35585226 | Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug |
| Q28066236 | Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do? |
| Q27489880 | Artemisinins: their growing importance in medicine |
| Q34675798 | Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production |
| Q38947280 | Artesunate induces necrotic cell death in schwannoma cells. |
| Q33861787 | Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo |
| Q35863615 | Comparative cytotoxicity of artemisinin and cisplatin and their interactions with chlorogenic acids in MCF7 breast cancer cells |
| Q37721809 | Cytotoxicity of Endoperoxides from the Caribbean Sponge Plakortis halichondrioides towards Sensitive and Multidrug-Resistant Leukemia Cells: Acids vs. Esters Activity Evaluation. |
| Q28297100 | DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma |
| Q34296810 | Development of artemisinin compounds for cancer treatment |
| Q28478307 | Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells |
| Q90356237 | Dihydroartemisinin Prevents Distant Metastasis of Laryngeal Carcinoma by Inactivating STAT3 in Cancer Stem Cells |
| Q37412018 | Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells |
| Q34740860 | Dihydroartemisinin promotes angiogenesis during the early embryonic development of zebrafish |
| Q47700711 | Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein |
| Q36734783 | EM23, A Natural Sesquiterpene Lactone from Elephantopus mollis, Induces Apoptosis in Human Myeloid Leukemia Cells through Thioredoxin- and Reactive Oxygen Species-Mediated Signaling Pathways |
| Q39983375 | Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells |
| Q33436238 | Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature |
| Q28471656 | Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target |
| Q33587295 | Interaction of translationally controlled tumor protein with Apaf-1 is involved in the development of chemoresistance in HeLa cells |
| Q27480937 | Molecular biology of cantharidin in cancer cells |
| Q64863265 | Neuroprotective Effect of Artesunate in Experimental Model of Traumatic Brain Injury |
| Q38344438 | Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines. |
| Q37412316 | Quality of evidence about effectiveness of treatments for metastatic uveal melanoma. |
| Q37320297 | Recent advances in artemisinin production through heterologous expression |
| Q24645584 | Redox-directed cancer therapeutics: molecular mechanisms and opportunities |
| Q91596406 | Retrospective study of small pet tumors treated with Artemisia annua and iron |
| Q33295383 | Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate |
| Q26780167 | Sesquiterpene Lactones from Artemisia Genus: Biological Activities and Methods of Analysis |
| Q36243168 | Sesquiterpene lactone! a promising antioxidant, anticancer and moderate antinociceptive agent from Artemisia macrocephala jacquem |
| Q37144488 | Small Molecular-Sized Artesunate Attenuates Ocular Neovascularization via VEGFR2, PKCα, and PDGFR Targets |
| Q46863380 | Synergic effects of artemisinin and resveratrol in cancer cells |
| Q52629734 | Synergistic anticancer activities of the plant-derived sesquiterpene lactones salograviolide A and iso-seco-tanapartholide. |
| Q42923682 | Synergistic inhibition of angiogenesis by artesunate and captopril in vitro and in vivo |
| Q51048652 | The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells. |
| Q39425405 | The effects of artesunate on the expression of EGFR and ABCG2 in A549 human lung cancer cells and a xenograft model. |
| Q22061955 | The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis |
| Q37732720 | Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia annua |
| Q52593710 | Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds. |
Search more.